10月5日，太美医疗科技（股票代码：02576）发布翌日披露报表，公告其于当日在香港联合交易所回购H股2.00万股，占本次事件前已发行股本约0.01%。每股回购价格区间为港币4.58元至4.96元，总耗资约9.55万港元。
本次回购完成后，公司已发行股份总数（含库藏股）仍为200,592,533股，其中已发行股份（不包括库藏股）为193,207,733股；库藏股数量增至7,384,800股。回购授权于2026年6月23日获得股东大会通过，授权可回购的股份合计为20,017,153股，截至目前公司已累计回购6,963,800股。
公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。本公告由执行董事及联席公司秘书倪晓梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.